Switch to: References

Add citations

You must login to add citations.
  1. Adapt to Translate – Adaptive Clinical Trials and Biomedical Innovation.Daria Jadreškić - 2021 - European Journal of Analytic Philosophy 17 (2):(SI3)5-24.
    The article presents the advantages and limitations of adaptive clinical trials for assessing the effectiveness of medical interventions and specifies the conditions that contributed to their development and implementation in clinical practice. I advance two arguments by discussing different cases of adaptive trials. The normative argument is that responsible adaptation should be taken seriously as a new way of doing clinical research insofar as a valid justification, sufficient understanding, and adequate operational conditions are provided. The second argument is historical. The (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Why translational medicine is, in fact, “new,” why this matters, and the limits of a predominantly epistemic historiography.Mark Robinson - 2020 - History and Philosophy of the Life Sciences 42 (3):1-22.
    Is Translational Science and Medicine new? Its dramatic expansion has spelled a dizzying array of new disciplines, departments, buildings, and terminology. Yet, without novel theories or concepts, Translational Science and Medicine may appear to be nothing more than an old concept with a new brand. Yet, is this view true? As is illustrated herein, histories of TSM which treat it as merely an old product under a new name misunderstand its essential architecture. As an expressly economic transformation, modern translational approaches (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • The promise and perils of industry‐funded science.Bennett Holman & Kevin C. Elliott - 2018 - Philosophy Compass 13 (11).
    Private companies provide by far the most funding for scientific research and development. Nevertheless, relatively little attention has been paid to the dynamics of industry‐funded research by philosophers of science. This paper addresses this gap by providing an overview of the major strengths and weaknesses of industry research funding, together with the existing recommendations for addressing the weaknesses. It is designed to provide a starting point for future philosophical work that explores the features of industry‐funded research, avenues for addressing concerns, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   22 citations  
  • Experimentation by Industrial Selection.Bennett Holman & Justin Bruner - 2017 - Philosophy of Science 84 (5):1008-1019.
    Industry is a major source of funding for scientific research. There is also a growing concern for how it corrupts researchers faced with conflicts of interest. As such, the debate has focused on whether researchers have maintained their integrity. In this article we draw on both the history of medicine and formal modeling to argue that given methodological diversity and a merit-based system, industry funding can bias a community without corrupting any particular individual. We close by considering a policy solution (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   47 citations  
  • Broadening the scope of our understanding of mechanisms: lessons from the history of the morning-after pill.Christopher ChoGlueck - 2021 - Synthese 198 (3):2223-2252.
    Philosophers of science and medicine now aspire to provide useful, socially relevant accounts of mechanism. Existing accounts have forged the path by attending to mechanisms in historical context, scientific practice, the special sciences, and policy. Yet, their primary focus has been on more proximate issues related to therapeutic effectiveness. To take the next step toward social relevance, we must investigate the challenges facing researchers, clinicians, and policy makers involving values and social context. Accordingly, we learn valuable lessons about the connections (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • Drug Labels and Reproductive Health: How Values and Gender Norms Shape Regulatory Science at the FDA.Christopher ChoGlueck - 2019 - Dissertation, Indiana University
    The US Food and Drug Administration (FDA) is fraught with controversies over the role of values and politics in regulatory science, especially with drugs in the realm of reproductive health. Philosophers and science studies scholars have investigated the ways in which social context shapes medical knowledge through value judgments, and feminist scholars and activists have criticized sexism and injustice in reproductive medicine. Nonetheless, there has been no systematic study of values and gender norms in FDA drug regulation. I focus on (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
    		•